108 related articles for article (PubMed ID: 24531350)
41. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
[TBL] [Abstract][Full Text] [Related]
42. Ferucarbotran-enhanced T2-weighted magnetic resonance imaging: differentiation of hepatic cavernous hemangiomas from malignant solid lesions.
Cho ES; Yu JS; Ahn JH; Park MS; Kim JH; Chung JJ; Kim KW
Abdom Imaging; 2009 Jul; 34(4):494-501. PubMed ID: 18546032
[TBL] [Abstract][Full Text] [Related]
43. Sclerosed hemangioma of the liver: concordance of MRI features with histologic characteristics.
Ridge CA; Shia J; Gerst SR; Do RK
J Magn Reson Imaging; 2014 Apr; 39(4):812-8. PubMed ID: 24783239
[TBL] [Abstract][Full Text] [Related]
44. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT.
Kim T; Federle MP; Baron RL; Peterson MS; Kawamori Y
Radiology; 2001 Jun; 219(3):699-706. PubMed ID: 11376257
[TBL] [Abstract][Full Text] [Related]
45. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient.
Namimoto T; Nakagawa M; Kizaki Y; Itatani R; Kidoh M; Utsunomiya D; Oda S; Yamashita Y
J Comput Assist Tomogr; 2015; 39(4):453-61. PubMed ID: 25836022
[TBL] [Abstract][Full Text] [Related]
47. Cavernous hemangioma of the liver: pathologic correlation with high-field MR imaging.
Tung GA; Vaccaro JP; Cronan JJ; Rogg JM
AJR Am J Roentgenol; 1994 May; 162(5):1113-7. PubMed ID: 8165993
[TBL] [Abstract][Full Text] [Related]
48. Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison.
Homayoon B; Diwakar H; Strovski E; Bakshi D; Harris AC; Thoeni RF; Chang SD
Abdom Imaging; 2014 Oct; 39(5):955-62. PubMed ID: 24676875
[TBL] [Abstract][Full Text] [Related]
49. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
Watanabe H; Kanematsu M; Goshima S; Kajita K; Kawada H; Noda Y; Tatahashi Y; Kawai N; Kondo H; Moriyama N
Acta Radiol; 2014 Dec; 55(10):1166-73. PubMed ID: 24316660
[TBL] [Abstract][Full Text] [Related]
50. Hyperechoic and hypoechoic hepatic hemangiomas smaller than 3 cm seldom coexist.
Wu S; Tu R; Liu G; Guan Y; Zhao Y
Ultrasound Q; 2014 Dec; 30(4):291-4. PubMed ID: 25415867
[TBL] [Abstract][Full Text] [Related]
51. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
52. [MRI and ultrasonography of cavernous hemangioma of the liver].
Matsumoto K; Nakajima T; Niitsu M; Anno I; Akisada M; Matsuzaki Y
Rinsho Hoshasen; 1989 Aug; 34(8):851-6. PubMed ID: 2585759
[TBL] [Abstract][Full Text] [Related]
53. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of cavernous hemangioma from schwannoma of the orbit: a dynamic MRI study.
Tanaka A; Mihara F; Yoshiura T; Togao O; Kuwabara Y; Natori Y; Sasaki T; Honda H
AJR Am J Roentgenol; 2004 Dec; 183(6):1799-804. PubMed ID: 15547232
[TBL] [Abstract][Full Text] [Related]
55. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging.
Li KC; Glazer GM; Quint LE; Francis IR; Aisen AM; Ensminger WD; Bookstein FL
Radiology; 1988 Nov; 169(2):409-15. PubMed ID: 3174988
[TBL] [Abstract][Full Text] [Related]
56. Atypical cavernous hemangioma of the liver.
Itai Y; Ohtomo K; Kokubo T; Yamauchi T; Tanioka H; Yoshikawa K; Yashiro N
Radiat Med; 1988; 6(3):135-40. PubMed ID: 3200999
[TBL] [Abstract][Full Text] [Related]
57. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
58. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
[TBL] [Abstract][Full Text] [Related]
59. [Liver hemangiomas--diagnostic and treatment strategy].
Treska V; Ferda J; Skalický T; Sutnar A; Liska V
Rozhl Chir; 2007 Jan; 86(1):28-31. PubMed ID: 17416076
[TBL] [Abstract][Full Text] [Related]
60. CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid.
Budjan J; Ong M; Riffel P; Morelli JN; Michaely HJ; Schoenberg SO; Haneder S
Eur J Radiol; 2014 Nov; 83(11):2007-12. PubMed ID: 25172427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
